Antonio Salar

26PUBLICATIONS
111CO-AUTHORS
Predictive and prognostic markersMolecular targetsPersonality and individual differencesCancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Mar 14, 2026
Tumor Mutational Burden as a Prognostic Biomarker in Follicular Lymphoma.

Marta Lafuente, Ramón Diez-Feijóo, Marta García-Recio

|Dec 22, 2025
Efficacy and Safety of Capivasertib (AZD5363), a Potent, Oral Pan-AKT Inhibitor, in Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (CAPITAL).

Daniel J Hodson, Geoffrey Shouse, Ho-Jin Shin

|Jun 13, 2025
From Clinical Perception to Implicit Bias: Understanding Personality Traits in Lymphoma Patients.

Fátima Roso-Bas, María Dolores Alonso-Llobregat, Leyre Bento

|Apr 13, 2024
Comparing R-Bendamustine vs. R-CHOP Plus Maintenance Therapy as First-Line Systemic Treatment in Follicular Lymphoma: A Multicenter Retrospective GELTAMO Study.

Mariana Bastos-Oreiro, Antonio Gutierrez, Almudena Cabero

|Jan 23, 2024
Cell-Free DNA as a Biomarker at Diagnosis and Follow-Up in 256 B and T-Cell Lymphomas.

Ramón Diez-Feijóo, Marcio Andrade-Campos, Joan Gibert

|Jun 30, 2023
Low-risk HPLLs/ABC score patients with splenic marginal zone lymphoma can be safely managed without treatment: Results from a prospective Spanish study.

Ana Muntañola, María Teresa Villalobos, Sonia González-Villambrosia

Pageof 5

Frequent Collaborators

6 joint publications

Luis Colomo

5 joint publications

Marta Salido

5 joint publications

Nieves Garcia-Gisbert

5 joint publications

Antonio Gutiérrez